I present a simple analytical model in continuous time where individuals can be either healthy or ill, and have constant transition between the states and constant mortality rates in each state. The values from being in each of the two live states are represented by two Bellman dynamic programming equations. This leads to simple expressions for lifetime values of remaining in each of the states, values of statistical life in good health (VSL) and of statistical illness (VSI), the value of improved health, and the value of health investments. Changes in background risks have intuitively reasonable effects on VSL and VSI, while a “dead-anyway effect ” only appears in the valuation of health investment but not in expressions of VSL or VSI. I a...
The central statistical problem of survival analysis is to determine and characterize the conditiona...
An important issue which has been raised in the measurement of health status is the effect that the ...
The author studies three aspects of human live valuation and its relation with and cost benefit anal...
This paper develops two straightforward value of life models; one is a probabilistic value of life m...
What is the value of a statistical life (VSL)? How does one calculate such a value? Does everyone’s ...
The value of a statistical life (VSL) is a popular way to quantify the benefits of mortality risk re...
Continuous-time state transition models may end up having large unwieldy structures when trying to r...
Continuous-time state transition models may end up having large unwieldy structures when trying to r...
Continuous-time state transition models may end up having large unwieldy structures when trying to r...
A choice model based on utility in each of a sequence of prospective future health states permits us...
Government agencies routinely use the “value of a statistical life” (VSL) in benefit-cost analyses o...
International audienceEconomic valuation of health risks plays an important role in informing decisi...
Methods of estimating the value of statistical life (VSL) have evolved over time, namely human capit...
The monetary value of preventing one statistical death is usually defined as the value of a statisti...
James Broughel wants to break the link between the willingness-to-pay principle embodied in the valu...
The central statistical problem of survival analysis is to determine and characterize the conditiona...
An important issue which has been raised in the measurement of health status is the effect that the ...
The author studies three aspects of human live valuation and its relation with and cost benefit anal...
This paper develops two straightforward value of life models; one is a probabilistic value of life m...
What is the value of a statistical life (VSL)? How does one calculate such a value? Does everyone’s ...
The value of a statistical life (VSL) is a popular way to quantify the benefits of mortality risk re...
Continuous-time state transition models may end up having large unwieldy structures when trying to r...
Continuous-time state transition models may end up having large unwieldy structures when trying to r...
Continuous-time state transition models may end up having large unwieldy structures when trying to r...
A choice model based on utility in each of a sequence of prospective future health states permits us...
Government agencies routinely use the “value of a statistical life” (VSL) in benefit-cost analyses o...
International audienceEconomic valuation of health risks plays an important role in informing decisi...
Methods of estimating the value of statistical life (VSL) have evolved over time, namely human capit...
The monetary value of preventing one statistical death is usually defined as the value of a statisti...
James Broughel wants to break the link between the willingness-to-pay principle embodied in the valu...
The central statistical problem of survival analysis is to determine and characterize the conditiona...
An important issue which has been raised in the measurement of health status is the effect that the ...
The author studies three aspects of human live valuation and its relation with and cost benefit anal...